News Posted on December 5, 2025 Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC Merger – MedCity News Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC Merger MedCity News Source: Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via 0M SPAC Merger – MedCity News By sf-admin